{
 "PrintNo":"S5314","Session":2025,"Chamber":"SENATE","BillType":"Senate","Published":"2025-02-20T14:33:37.147863Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2025-02-20","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2025-02-20","Chamber":"SENATE"}],
 "Sponsors":[{"ID":1102,"Name":"Jamaal Bailey","Short":"BAILEY"}],
 "Title":"Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy",
 "Summary":"Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain \"brown bagging\" and \"white bagging\" policies regarding pharmacy provided medications.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3217-b & 4325, Ins L; amd §4406-c, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to establishing patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy",
 "SameAsPrintNo":"A1720-2025","PreviousVersions":["S7252-2021","S7413-2023"]
}